BIBF 1120 for Recurrent High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Phase I Study of AbGn-168H in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Ambroxol Spray Sore Throat Study
- Status
- COMPLETED
- Phase
- PHASE2
To Assess the Bioequivalence of Brotizolam Tablets 250 Mcg vs. Lendormin Tablets 250 Mcg Administered to Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients
- Status
- COMPLETED
- Phase
- N/A
GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension
- Status
- COMPLETED
- Phase
- N/A
BIBF 1120 and RAD001 in Solid Tumors - Phase I
- Status
- COMPLETED
- Phase
- PHASE1
BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers
- Status
- TERMINATED
- Phase
- PHASE1
Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.
- Status
- COMPLETED
- Phase
- PHASE1
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
- Status
- TERMINATED
- Phase
- PHASE3
Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use
- Status
- COMPLETED
- Phase
- PHASE1